Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Exlites Holdings International, Inc. (EXHI)

Compare
0.3420
0.0000
(0.00%)
At close: April 10 at 4:00:00 PM EDT
Loading Chart for EXHI
  • Previous Close 0.0000
  • Open 0.3417
  • Bid 0.0808 x --
  • Ask 0.3417 x --
  • Day's Range 0.3417 - 0.3417
  • 52 Week Range 0.2790 - 3.8000
  • Volume 300
  • Avg. Volume 80
  • Market Cap (intraday) 15.063M
  • Beta (5Y Monthly) -3.04
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Exlites Holdings International, Inc. manufactures and distributes medical products. The company distributes and manufactures therapeutic pain, exercise, weight loss, and DVT prevention systems for use by patients. It sells proprietary patented and patent pending health care products, such as deep vein thrombosis units, transcutaneous electrical nerve stimulation units, electronic muscle stimulation units, various bracing products, and other medical and consumer healthcare products. The company also focuses on electric vehicle range extenders. The company was founded in 1979 and is headquartered in Tampa, Florida.

exlitesholdings.us

--

Full Time Employees

January 31

Fiscal Year Ends

Recent News: EXHI

View More

Performance Overview: EXHI

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EXHI
8.06%
S&P 500 (^GSPC)
10.43%

1-Year Return

EXHI
32.94%
S&P 500 (^GSPC)
2.08%

3-Year Return

EXHI
91.00%
S&P 500 (^GSPC)
17.37%

5-Year Return

EXHI
1,610.00%
S&P 500 (^GSPC)
88.83%

Compare To: EXHI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EXHI

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    15.05M

  • Enterprise Value

    15.05M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.07%

  • Return on Assets (ttm)

    1.51%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    9.42M

  • Net Income Avi to Common (ttm)

    6.86k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    24.78k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -105.81k

Research Analysis: EXHI

View More

Company Insights: EXHI

Research Reports: EXHI

View More

People Also Watch